The use of interconnected β-tricalcium phosphate as bone substitute after curettage of benign bone tumours

Abstract

Objective The purpose of this study was to analyse the clinical and radiological outcome in patients after implantation of β-tricalcium phosphate as a bone graft substitute to fill the defects after curettage of benign bone tumours and tumour-like lesions.

Keywords

• bone tumour
• tricalcium phosphate
• biocompatibility
• bioresorbability